Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Sci Rep ; 14(1): 15416, 2024 07 04.
Artículo en Inglés | MEDLINE | ID: mdl-38965270

RESUMEN

Zinc oxide nanoparticles (ZnO NPs) are one of the most abundantly used nanomaterials in cosmetics and topical products, and nowadays, they are explored in drug delivery and tissue engineering. Some recent data evidenced that they are responsible for cardiotoxic effects and systemic toxicity. The present study aimed to investigate the toxic effect of ZnO NPs (39 nm) on the heart of Wistar rats and to perform a dose-response relationship using three different dose levels (25, 50, 100 mg/kg bw) of ZnO NPs on the electrocardiogram (ECG) readings, the levels of biochemical function parameters of heart, and the oxidative stress and antioxidant biomarkers. Furthermore, zinc concentration level and histopathological examination of heart tissues were determined. ZnO NPs showed a dose-dependent effect, as the 100 mg/kg bw ZnO NPs treated group showed the most significant changes in ECGs parameters: R-R distance, P-R interval, R and T amplitudes, and increased levels of heart enzymes Creatine Kinase- MB (CK-MB) and Lactate dehydrogenase (LDH). On the other hand, elevated zinc concentration levels, oxidative stress biomarkers MDA and NO, and decreased GSH levels were found also in a dose-dependent manner, the results were supported by impairment in the histopathological structure of heart tissues. While the dose of 100 mg/kg bw of ZnO bulk group showed no significant effects on heart function. The present study concluded that ZnO NPs could induce cardiac dysfunctions and pathological lesions mainly in the high dose.


Asunto(s)
Electrocardiografía , Corazón , Estrés Oxidativo , Ratas Wistar , Óxido de Zinc , Animales , Óxido de Zinc/toxicidad , Óxido de Zinc/química , Masculino , Ratas , Estrés Oxidativo/efectos de los fármacos , Corazón/efectos de los fármacos , Nanopartículas del Metal/toxicidad , Nanopartículas del Metal/química , Biomarcadores/metabolismo , Miocardio/metabolismo , Miocardio/patología , Antioxidantes/metabolismo , Antioxidantes/farmacología , Nanopartículas/toxicidad
2.
BMC Public Health ; 23(1): 2437, 2023 12 06.
Artículo en Inglés | MEDLINE | ID: mdl-38057749

RESUMEN

BACKGROUND: University students are more likely to experience stress, anxiety, and depression. All these factors are regarded as psychological contributors to fibromyalgia syndrome (FMS). AIM: To investigate the prevalence and determinants of FMS among university students and its impact on their health-related quality of life (HRQoL). METHODS: This online survey-based study involved 2146 university students who were recruited from various faculties at several Egyptian universities. The participants' demographics, medical history, academic pursuits, and sleep data were collected. To identify the existence of FMS, the 2016 updates to the 2010/2011 FMS diagnostic criteria were used. Additionally, the participants completed the Short-Form Health Survey-36 (SF-36). RESULTS: The mean age was 21.26 ± 2.015 years and 76% were females. Of 2146 students, 266 (12.4%) fulfilled the criteria of FMS. FMS group had a significantly lower age (p < 0.001) with predominant female gender (89.5% vs. 74.1%, p < 0.001), positive family history of FMS (8.6% vs. 3.7%, p < 0.001), previous history of traffic accident (10.2% vs. 6.8%, p = 0.045), lower level of physical activity (p = 0.002),higher time spent in study per week (p = 0.002), lower sleep time (p = 0.002), with frequent walk up (p < 0.001) and snoring (p < 0.001) during sleep. Regarding HRQoL, students with FMS had significantly lower scores than students without in all domains. CONCLUSION: FMS is prevalent among Egyptian university students and is linked to female gender, positive family history, lower levels of physical activity, and more time spent studying each week. FMS has a negative impact on HRQoL. Therefore, early detection and treatment are recommended.


Asunto(s)
Fibromialgia , Humanos , Femenino , Adulto Joven , Adulto , Masculino , Fibromialgia/diagnóstico , Fibromialgia/psicología , Fibromialgia/terapia , Egipto/epidemiología , Calidad de Vida/psicología , Prevalencia , Universidades , Encuestas y Cuestionarios
3.
Toxicol Ind Health ; 35(10): 627-637, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31694480

RESUMEN

Zinc oxide nanoparticles (ZnO NPs) are produced in high tonnage each year; they are widely used in consumer and industrial products, also now finding applications in bioimaging and drug delivery. In the present study, comparison between ZnO NPs (39 nm) and its bulk/micron form (particle size = 5 µm) on liver function of rats was determined. In our study, liver enzymes biomarkers, serum lipid profile, zinc concentration, and histopathological examination in liver tissues were used to evaluate liver injury. Moreover, lipid peroxidation (malondialdehyde), nitric oxide, and reduced glutathione levels were determined to detect the oxidation-reduction process in liver tissue. The results showed dose-dependent toxicity of ZnO NPs. Three different dose levels (25, 50, and 100 mg/kg bw) were used, and the 100-mg/kg bw ZnO NPs group showed the most significant changes in liver enzymes and histopathological structure, as well as redox state. The dose of 100 mg/kg bw of ZnO bulk group showed no significant effects on liver function. The study concluded that ZnO NPs caused hepatic impairments.


Asunto(s)
Hígado/efectos de los fármacos , Nanopartículas/química , Óxido de Zinc/química , Óxido de Zinc/toxicidad , Animales , Relación Dosis-Respuesta a Droga , Peroxidación de Lípido/efectos de los fármacos , Lípidos/sangre , Pruebas de Función Hepática , Masculino , Tamaño de la Partícula , Ratas , Ratas Wistar , Zinc/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA